×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANGO – angiodynamics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANGO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/24
08:21 am
ango
AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]
Low
Report
AngioDynamics launches long-term study of NanoKnife for prostate cancer [Yahoo! Finance]
10/23
02:15 pm
ango
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE [Yahoo! Finance]
Low
Report
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE [Yahoo! Finance]
10/23
08:00 am
ango
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
Medium
Report
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
10/22
10:56 am
ango
AngioDynamics' NanoKnife System gains CPT codes for prostate and liver treatments [Yahoo! Finance]
Medium
Report
AngioDynamics' NanoKnife System gains CPT codes for prostate and liver treatments [Yahoo! Finance]
10/21
08:00 am
ango
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
Medium
Report
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
10/4
01:35 pm
ango
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
AngioDynamics, Inc. (NASDAQ: ANGO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
10/4
11:36 am
ango
AngioDynamics, Inc. (NASDAQ: ANGO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $13.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
AngioDynamics, Inc. (NASDAQ: ANGO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $13.00 to $12.00. They now have a "buy" rating on the stock.
10/3
03:20 pm
ango
AngioDynamics slides after Q1 revenue miss [Seeking Alpha]
Medium
Report
AngioDynamics slides after Q1 revenue miss [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
10/23
05:06 pm
ango
Form SC 13G/A ANGIODYNAMICS INC Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A ANGIODYNAMICS INC Filed by: BlackRock, Inc.
10/10
03:23 pm
ango
Form 4 ANGIODYNAMICS INC For: Oct 07 Filed by: Nighan Warren JR
Low
Report
Form 4 ANGIODYNAMICS INC For: Oct 07 Filed by: Nighan Warren JR
10/8
06:28 pm
ango
Form 4 ANGIODYNAMICS INC For: Oct 08 Filed by: Trowbridge Stephen A
Low
Report
Form 4 ANGIODYNAMICS INC For: Oct 08 Filed by: Trowbridge Stephen A
10/8
04:32 pm
ango
Form 4 ANGIODYNAMICS INC For: Oct 07 Filed by: Clemmer James C
Low
Report
Form 4 ANGIODYNAMICS INC For: Oct 07 Filed by: Clemmer James C
10/3
05:09 pm
ango
Form 10-Q ANGIODYNAMICS INC For: Aug 31
Medium
Report
Form 10-Q ANGIODYNAMICS INC For: Aug 31
10/3
07:31 am
ango
Form 8-K ANGIODYNAMICS INC For: Oct 03
High
Report
Form 8-K ANGIODYNAMICS INC For: Oct 03
9/26
02:58 pm
ango
Form DEF 14A ANGIODYNAMICS INC For: May 31
Low
Report
Form DEF 14A ANGIODYNAMICS INC For: May 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
AngioDynamics, Inc. (NASDAQ: ANGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating.
14.7%
4/17 AngioDynamics, Inc. (NASDAQ: ANGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.1%
3/24 AngioDynamics, Inc. (NASDAQ: ANGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.4%
10/28 Form 4 ANGIODYNAMICS INC For: Oct 25 Filed by: Clemmer James C 4.7%
10/3 AngioDynamics, Inc. 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 4.5%
7/10 AngioDynamics (ANGO) Q4 2019 Earnings Call Transcript [The Motley Fool] 4.0%
7/10 Q4/2019 5/31/2019 EPS 0.250 ZacksConsensus 0.250 ActVsEst 0.000 - In-Line 2.7%
2/18 Form 4 ANGIODYNAMICS INC For: Feb 12 Filed by: Boucher Brent J. 2.6%
1/6 AngioDynamics to Present at the J.P. Morgan Healthcare Conference 2.5%
1/16 AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System 2.5%
4/17 AngioDynamics, Inc. (NASDAQ: ANGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.1%
3/24 AngioDynamics, Inc. (NASDAQ: ANGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.4%
10/28 Form 4 ANGIODYNAMICS INC For: Oct 25 Filed by: Clemmer James C 4.7%
10/3 AngioDynamics, Inc. 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 4.5%
7/10 AngioDynamics (ANGO) Q4 2019 Earnings Call Transcript [The Motley Fool] 4.0%
7/10 Q4/2019 5/31/2019 EPS 0.250 ZacksConsensus 0.250 ActVsEst 0.000 - In-Line 2.7%
2/18 Form 4 ANGIODYNAMICS INC For: Feb 12 Filed by: Boucher Brent J. 2.6%
1/6 AngioDynamics to Present at the J.P. Morgan Healthcare Conference 2.5%
1/16 AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System 2.5%
TOP News Decliners
10/3
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
-14.4%
1/7 Form 8-K ANGIODYNAMICS INC For: Jan 07 -12.1%
7/10 Form 8-K ANGIODYNAMICS INC For: Jul 10 -10.9%
4/7 AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
3/10 AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020 -6.6%
2/7 Form 8-K ANGIODYNAMICS INC For: Feb 05 -5.9%
4/7 Form 4 ANGIODYNAMICS INC For: Apr 04 Filed by: Clemmer James C -4.7%
10/3 Why GoPro, AngioDynamics, and Resources Connection Slumped Today [The Motley Fool] -3.7%
1/21 Form 4 ANGIODYNAMICS INC For: Jan 17 Filed by: Boucher Brent J. -3.6%
10/7 Accelmed seeks to raise $100 million for fourth health tech fund [Reuters] -3.6%
1/7 Form 8-K ANGIODYNAMICS INC For: Jan 07 -12.1%
7/10 Form 8-K ANGIODYNAMICS INC For: Jul 10 -10.9%
4/7 AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
3/10 AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020 -6.6%
2/7 Form 8-K ANGIODYNAMICS INC For: Feb 05 -5.9%
4/7 Form 4 ANGIODYNAMICS INC For: Apr 04 Filed by: Clemmer James C -4.7%
10/3 Why GoPro, AngioDynamics, and Resources Connection Slumped Today [The Motley Fool] -3.7%
1/21 Form 4 ANGIODYNAMICS INC For: Jan 17 Filed by: Boucher Brent J. -3.6%
10/7 Accelmed seeks to raise $100 million for fourth health tech fund [Reuters] -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: